|
|
|
ix | |
| Introduction |
|
|
Inflammation -- a new frontier in cardiac disease and therapeutics |
|
|
1 | (8) |
|
|
|
|
|
|
|
Pathological aspects and inflammation biomarkers in cardiac diseases |
|
|
|
A biomarker of inflammation in cardiovascular diseases |
|
|
9 | (12) |
|
|
|
|
|
|
|
|
|
Inflammation and coronary artery disease |
|
|
21 | (36) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Inflammatory cells and their metalloproteinases in cardiac diseases |
|
|
|
The role of matrix metalloproteinases in LV remodeling following myocardial infarction |
|
|
57 | (20) |
|
|
|
|
|
|
|
|
|
Matrix metalloproteinases in heart failure: evidence from experimental models |
|
|
77 | (18) |
|
|
|
Inflammatory cytokines in cardiac diseases |
|
|
|
The clinical experience with anti-cytokine therapy in heart failure |
|
|
95 | (16) |
|
|
|
|
|
|
|
The role of IL-6 and related cytokines in myocardial remodeling and inflammation -- implication for cardiac hypertrophy and heart failure |
|
|
111 | (18) |
|
|
|
|
|
Toll-like receptors and the cardiovascular system |
|
|
129 | (14) |
|
|
|
|
|
|
|
The role of IL-6 in experimental and clinical heart failure |
|
|
143 | (12) |
|
|
|
|
|
Oxygen and nitrogen reactive radicals in cardiac inflammation and disease |
|
|
|
Myocardial nitric oxide in cardiac remodeling |
|
|
155 | (16) |
|
|
|
|
|
|
|
Identification and role of inflammatory oxygen free radicals in cardiac ischemia and reperfusion injury |
|
|
171 | (18) |
|
|
|
|
|
|
|
|
|
|
|
The immune and complement system and cardiac diseases |
|
|
|
Immune-mediated myocarditis and interleukin-10 |
|
|
189 | (14) |
|
|
|
|
|
|
|
Immunomodulation in heart failure: experimental models |
|
|
203 | (18) |
|
|
|
The role of complement in myocardial inflammation and reperfusion injury |
|
|
221 | (30) |
|
|
|
|
|
Inflammatory signaling pathways in cardiac diseases |
|
|
|
The role of immune and inflammatory cytokines in ischemic preconditioning of the heart -- identification of novel cardiac cell survival signaling programs |
|
|
251 | (20) |
|
|
|
|
|
|
|
Stress-activated signals and their role in myocardial ischemia |
|
|
271 | (22) |
|
|
|
|
|
p38 MAPK in cardiac remodeling and failure: cytokine signaling and beyond |
|
|
293 | (22) |
|
|
|
|
|
|
|
|
|
Inflammation and myocarditis |
|
|
|
Inflammation and myocarditis |
|
|
315 | (10) |
|
|
|
The inflammatory process in experimental myocarditis |
|
|
325 | (12) |
|
|
|
|
|
Nuclear factors in cardiac disease |
|
|
|
Peroxisome proliferator activated receptors, inflammation, the vasculature and the heart |
|
|
337 | (14) |
|
|
|
|
|
|
|
Chemokines and cardiac diseases |
|
|
|
Role of chemokines in the pathogenesis of congestive heart failure |
|
|
351 | (20) |
|
|
|
|
|
|
|
Neurohormonal mediators and cardiac inflammation |
|
|
|
The role of endothelin-1 in myocardial inflammation and fibrosis |
|
|
371 | (16) |
|
|
|
|
|
|
|
Cyclooxygenases and cardiac diseases |
|
|
|
Cyclo-oxygenase-2 and myocardial ischemia |
|
|
387 | (12) |
|
|
|
Caroline P.D. Wheeler-Jones |
|
|
Inflammation and arrhythmias |
|
|
|
Inflammation as a cause and consequence of atrial fibrillation |
|
|
399 | (8) |
|
|
|
|
|
Summary: Immune and inflammatory modulators as potential therapeutic targets for cardiac diseases |
|
|
407 | (4) |
|
|
|
|
|
|
| Index |
|
411 | |
